Oregon's November approval of Measure 110 decriminalizing drug possession represents a landmark shift in criminal justice and addiction policy, redirecting individuals caught with small amounts of controlled substances from...
In a troubling development for children’s mental health, new data from the Centers for Medicare & Medicaid Services (CMS) reveals a significant and sustained...
Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to...
In a bold move to address the nation’s growing behavioral health needs, the Centers for Medicare & Medicaid Services (CMS) has unveiled new guidance...
The opioid epidemic continues to evolve, with a new and alarming development: nitazenes overdose risk is becoming a critical concern for clinicians, public health...
Accompany Health has secured $56 million in Series A funding to expand its mission of delivering integrated care for low-income patients. Based in Bethesda,...